KZR-616

KZR-616 · Kezar Life Sciences

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for KZR-616, covering 2024-01-03 to 2024-06-05. Get the full timeline:

Most recent: Clinical Trial Update: Open-label Extension to the Phase 2 Crossover Study (PRESIDIO) Evaluating KZR-616 in Patients With PM and DM. [Phase 2]

See pricing